JAGX · Jaguar Health, Inc. · Exempt Offerings
$2.59
-0.04 (-1.52%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions, along with recurring operating losses and an accumulated deficit, raise substantial doubt about the Company's ability to continue as a going concern for a period of one year from the issuance of these consolidated financial statements. While management believes this infusion improves our liquidity, it does not fully alleviate the conditions that raise substantial doubt about our ability to continue as a going concern for one year from the issuance of these financial statements.”View the 10-Q filed Aug 19, 2026
Market Cap
$1.81M
Shares
689,107
Volume · Oct 20
265.7K
Avg daily vol (3 sessions)
557.43K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-07-01 | New | Pharmaceuticals | $2,000,000 | $2,000,000 | 06b |
| 2026-07-01 | New | Pharmaceuticals | $40,800,000 | $40,800,000 | 06b |
| 2025-11-24 | New | Pharmaceuticals | $10,810,000 | $10,810,000 | 06b |
| 2025-10-10 | New | Pharmaceuticals | $1,000,000 | $1,000,000 | 06b |
| 2025-09-23 | New | Pharmaceuticals | $2,377,000 | $2,377,000 | 06b |
| 2025-05-28 | New | Pharmaceuticals | $1,500,003 | $1,500,003 | 06b |
| 2023-11-30 | New | Pharmaceuticals | $60,000 | $60,000 | 06b |
| 2023-05-11 | New | Pharmaceuticals | $1,832,304 | $1,832,304 | 06b |
| 2023-05-11 | New | Pharmaceuticals | $1,857,453 | $1,857,453 | 06b |
| 2022-09-23 | New | Pharmaceuticals | $7,140 | $7,140 | 06b |
| 2022-09-02 | New | Pharmaceuticals | $12,000,000 | $12,000,000 | 06b |
| 2022-07-08 | New | Pharmaceuticals | $10,000,000 | $300,000 | 06b |
| 2022-04-26 | New | Pharmaceuticals | $50,820 | $50,820 | 06b |
| 2022-04-25 | New | Pharmaceuticals | $39,800 | $39,800 | 06b |
| 2022-04-25 | New | Pharmaceuticals | $7,572 | $7,572 | 06b |
| 2021-09-24 | New | Pharmaceuticals | $776,197 | $776,197 | 06b |
| 2021-03-26 | New | Pharmaceuticals | $10,000,000 | $10,000,000 | 06b |
| 2021-02-04 | New | Pharmaceuticals | $6,220,812 | $6,220,812 | 06b |
| 2021-02-04 | New | Pharmaceuticals | $12,000,000 | $12,000,000 | 06b |
| 2020-09-17 | New | Pharmaceuticals | $1,087,500 | $1,087,500 | 06b |
| 2020-06-05 | New | Pharmaceuticals | $4,447,779 | $4,447,779 | 06b |
| 2020-04-08 | New | Pharmaceuticals | $720,000 | $720,000 | 06b |
| 2020-04-07 | New | Pharmaceuticals | $2,030,000 | $2,030,000 | 06b |
| 2020-01-06 | New | Pharmaceuticals | $1,500,000 | $1,500,000 | 06b |
Showing 1–24 of 24 filings